Companies / Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc.

Nasdaq: MISTCanadaCIK 1408443MONTREAL, Canada

Financials

Revenue—
Net income$-63.06M
Total debt$59.21M
Cash$169.73M
Diluted EPS$-0.75
Shares outstanding124.5M

Ownership

124.5M shares outstanding · as of Aug 12, 2026
0.76%Insiders
Ownership
Insiders0.76%951,027
10%+ / strategic7.28%9,067,848
Institutions23.73%29,549,409
Public float68.22%84,929,696

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
Oliveto JosephCEOPresident and CEO · Director
0.39%482,744
Muller LorenzChief Commercial Officer
0.16%205,406
Bharucha DavidChief Medical Officer
0.09%113,181
Hasija AmitCFO & EVP of Corp. Development
0.08%99,848
Nelson Jeffrey EdwardChief Operating Officer
0.04%49,848
Papa Joseph CDirector
——
Sandoval David I.GC & Chief Compliance Officer
——

Institutional holders 85

View all →
HolderValue% of shares
Pavaki Capital Management LLC$12.15M7.28%
Propel Bio Management, LLC$8.32M3.31%
Adage Capital Partners Gp, L.L.C.$5.68M2.26%
RTW Investments, LP$5.06M2.01%
Simplify Asset Management Inc.$3.04M1.21%
Two Sigma Investments, LP$2.76M1.86%
Marshall Wace, LLP$2.31M1.56%
Jane Street Group, LLC$2.21M0.88%
Pathstone Holdings, LLC$2.10M0.82%
Millennium Management LLC$1.84M1.24%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Adage Capital Partners Gp, L.L.C.
13F manager
ExitCommon stock$-5.68M-2.8M
-100.00%
0
medium
Q1 2026
as of
Millennium Management LLC
13F manager
AddCommon stock$1.36M+1.1M
+283.55%
1,544,325
1.24% of shares
low
Q3 2025
as of
Boxer Capital Management, LLC
13F manager
NewCommon stock$1.33M+667K
666,666
0.54% of shares
low
Q1 2026
as of
Balyasny Asset Management L.P.
13F manager
NewCommon stock$1.01M+851K
851,325
0.68% of shares
low
Q1 2026
as of
Two Sigma Investments, LP
13F manager
AddCommon stock$955.2K+803K
+53.00%
2,317,176
1.86% of shares
low
Q1 2023
as of
Barclays PLC
13F manager
AddCommon stock$809.6K+205K
+32.04%
846,828
0.68% of shares
low
Q1 2026
as of
Pavaki Capital Management LLC
13F manager
AddCommon stock$671.1K+564K
+6.64%
9,062,848
7.28% of shares
low
Q4 2023
as of
Barclays PLC
13F manager
TrimCommon stock$-651.8K-390K
-60.47%
255,185
0.20% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Pavaki Capital Management LLCPassive13G—9,067,848—
Trails Edge Capital Partners, LPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
MIST——59935V107—